Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Changes in HLA-DR expression, cytokine production and coagulation following endotoxin infusion in healthy human volunteers.

Mant TG, Borozdenkova S, Bradford DB, Allen E, Amin DM, Toothaker RD, Collins RW, Hargreaves RE, Jurcevic S.

Int Immunopharmacol. 2008 May;8(5):701-7. doi: 10.1016/j.intimp.2008.01.014. Epub 2008 Feb 11.

PMID:
18387512
2.

A negative regulatory role in mouse cardiac transplantation for a splice variant of CD80.

Bugeon L, Wong KK, Rankin AM, Hargreaves RE, Dallman MJ.

Transplantation. 2006 Nov 27;82(10):1334-41.

PMID:
17130783
3.

Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection.

Lin T, Zhou W, Farrar CA, Hargreaves RE, Sheerin NS, Sacks SH.

Am J Pathol. 2006 Apr;168(4):1241-8.

4.

Transplant tolerance: models, concepts and facts.

Monk NJ, Hargreaves RE, Simpson E, Dyson JP, Jurcevic S.

J Mol Med (Berl). 2006 Apr;84(4):295-304. Epub 2006 Feb 25. Review.

PMID:
16501935
5.

Complement activation regulates the capacity of proximal tubular epithelial cell to stimulate alloreactive T cell response.

Li K, Patel H, Farrar CA, Hargreaves RE, Sacks SH, Zhou W.

J Am Soc Nephrol. 2004 Sep;15(9):2414-22.

6.

Selective depletion of activated T cells: the CD40L-specific antibody experience.

Hargreaves RE, Monk NJ, Jurcevic S.

Trends Mol Med. 2004 Mar;10(3):130-5. Review.

PMID:
15102356
7.

Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockade.

Monk NJ, Hargreaves RE, Marsh JE, Farrar CA, Sacks SH, Millrain M, Simpson E, Dyson J, Jurcevic S.

Nat Med. 2003 Oct;9(10):1275-80. Epub 2003 Sep 14.

PMID:
14502279
8.

Direct visualisation of cytomegalovirus-specific CD8+ T cells in renal transplant recipients.

Hilton RM, Hargreaves RE, Sacks SH, O'Callaghan CA.

Transplant Proc. 2002 Jun;34(4):1171-3. No abstract available.

PMID:
12072306
9.

Selective silencing of full-length CD80 but not IgV-CD80 leads to impaired clonal deletion of self-reactive T cells and altered regulation of immune responses.

Bugeon L, Hargreaves RE, Crompton T, Outram S, Rahemtulla A, Porter AC, Dallman MJ.

Eur J Immunol. 2001 Jan;31(1):118-27.

10.

Major histocompatibility complex class II-expressing endothelial cells induce allospecific nonresponsiveness in naive T cells.

Marelli-Berg FM, Hargreaves RE, Carmichael P, Dorling A, Lombardi G, Lechler RI.

J Exp Med. 1996 Apr 1;183(4):1603-12.

11.

Definition of sites on HLA-DR1 involved in the T cell response to staphylococcal enterotoxins E and C2.

Hargreaves RE, Brehm RD, Tranter H, Warrens AN, Lombardi G, Lechler RI.

Eur J Immunol. 1995 Dec;25(12):3437-44.

PMID:
8566035
12.

Inhibition of spontaneous allorosette formation in rats by serum from tolerant animals.

Gluckman JC, Hargreaves RE, Hellström KE.

Transplantation. 1974 May;17(5):495-502. No abstract available.

PMID:
4597179
13.

Fractionation of sera from operationally tolerant rats by DEAE cellulose chromatography; evidence that serum blocking factors are associated with IgG.

Wright PW, Hargreaves RE, Bernstein ID, Hellström I.

J Immunol. 1974 Mar;112(3):1267-70. No abstract available.

PMID:
4204561
14.

Supplemental Content

Loading ...
Support Center